This is a Validated Antibody Database (VAD) review about bovine C-kit, based on 28 published articles (read how Labome selects the articles), using C-kit antibody in all methods. It is aimed to help Labome visitors find the most suited C-kit antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
C-kit synonym: c-kit

BioLegend
mouse monoclonal (104D2)
  • flow cytometry; human; loading ...; fig ex1
BioLegend C-kit antibody (BioLegend, 104D2) was used in flow cytometry on human samples (fig ex1). Nature (2019) ncbi
mouse monoclonal (104D2)
  • flow cytometry; human; loading ...; fig s2b
BioLegend C-kit antibody (Biolegend, 313219) was used in flow cytometry on human samples (fig s2b). Cell (2019) ncbi
mouse monoclonal (104D2)
  • flow cytometry; human; loading ...; fig 1a
BioLegend C-kit antibody (BioLegend, 104D2) was used in flow cytometry on human samples (fig 1a). PLoS ONE (2017) ncbi
mouse monoclonal (104D2)
  • flow cytometry; human; loading ...; fig 3a
BioLegend C-kit antibody (Biolegend, 104D2) was used in flow cytometry on human samples (fig 3a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (104D2)
  • flow cytometry; human; fig 2
In order to study the involvement of Notch signaling in NK cell lineage determination, BioLegend C-kit antibody (biolegend, 104D2) was used in flow cytometry on human samples (fig 2). J Immunol (2017) ncbi
mouse monoclonal (104D2)
  • flow cytometry; human; fig 5b
In order to investigate the protective effect of single domain camelid antibodies against botulinum neurotoxin, BioLegend C-kit antibody (biolegend, 313217) was used in flow cytometry on human samples (fig 5b). Nat Commun (2017) ncbi
mouse monoclonal (104D2)
  • flow cytometry; human; loading ...; fig 2b
BioLegend C-kit antibody (BioLegend, 104D2) was used in flow cytometry on human samples (fig 2b). Sci Rep (2017) ncbi
mouse monoclonal (104D2)
  • flow cytometry; human; loading ...; fig s6d
In order to map the lineage of human dendritic cells, BioLegend C-kit antibody (BioLegend, 104D2) was used in flow cytometry on human samples (fig s6d). Science (2017) ncbi
mouse monoclonal (104D2)
  • flow cytometry; human; loading ...; fig s1a
  • flow cytometry; mouse; loading ...; fig 4c
In order to study the differentiation of innate lymphoid cells, BioLegend C-kit antibody (Biolegend, 313218) was used in flow cytometry on human samples (fig s1a) and in flow cytometry on mouse samples (fig 4c). Cell (2017) ncbi
mouse monoclonal (104D2)
  • flow cytometry; human; 1:20; loading ...; fig ED7c
In order to define the interaction between LATS1/2 and the estrogen receptor signaling in breast cancer initiation., BioLegend C-kit antibody (BioLegend, 104D2) was used in flow cytometry on human samples at 1:20 (fig ED7c). Nature (2017) ncbi
mouse monoclonal (104D2)
  • flow cytometry; African green monkey; 1:100; fig 1
In order to study cell therapy for intrinsic urinary sphincter deficiency in nonhuman primates, BioLegend C-kit antibody (BioLegend, 104D2) was used in flow cytometry on African green monkey samples at 1:100 (fig 1). Stem Cell Res Ther (2017) ncbi
mouse monoclonal (104D2)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend C-kit antibody (biolegend, 104D2) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (104D2)
BioLegend C-kit antibody (BioLegend, 313212) was used . Sci Rep (2015) ncbi
mouse monoclonal (104D2)
  • flow cytometry; human; fig s1
In order to describe a highly sensitive microfluidic assay to detect acute myeloid leukemia, BioLegend C-kit antibody (Biolegend, 104D2) was used in flow cytometry on human samples (fig s1). Analyst (2016) ncbi
mouse monoclonal (104D2)
  • flow cytometry; mouse; loading ...; fig s2d
In order to assess the effects of allosteric inhibitors on different mutant forms of isocitrate dehydrogenase 1 in leukemia, BioLegend C-kit antibody (Biolegend, 104D2) was used in flow cytometry on mouse samples (fig s2d). Nat Chem Biol (2015) ncbi
mouse monoclonal (104D2)
  • flow cytometry; human; loading ...; fig 2c
In order to define a differentiation system to generate definitive hematopoietic multipotent progenitor cells from hemato-endothelial progenitors via the endothelial monolayer, BioLegend C-kit antibody (BioLegend, 104D2) was used in flow cytometry on human samples (fig 2c). J Cell Physiol (2016) ncbi
mouse monoclonal (104D2)
  • flow cytometry; human
In order to identify the cell surface markers in synovial mesenchymal stem cells, BioLegend C-kit antibody (Biolegend, 313206) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (104D2)
  • flow cytometry; human
BioLegend C-kit antibody (Biolegend, 313206) was used in flow cytometry on human samples . Cancer Lett (2015) ncbi
mouse monoclonal (104D2)
  • flow cytometry; human; fig 1
In order to study and identify critical cell lineage-dependent transduction bias to model breast cancer properly, BioLegend C-kit antibody (BioLegend, 104D2) was used in flow cytometry on human samples (fig 1). Nat Commun (2015) ncbi
mouse monoclonal (104D2)
  • flow cytometry; human
BioLegend C-kit antibody (Biolegend, Clone 104D2) was used in flow cytometry on human samples . Int J Infect Dis (2015) ncbi
mouse monoclonal (104D2)
  • flow cytometry; human
BioLegend C-kit antibody (Biolegend, 104D2) was used in flow cytometry on human samples . Mol Biol Cell (2015) ncbi
mouse monoclonal (104D2)
  • immunohistochemistry; human; tbl 4
In order to describe protocols to directed differentiation of protein folding disease-specific iPSCs into hepatocytes and neural-lineage cells, BioLegend C-kit antibody (BioLegend, 313206) was used in immunohistochemistry on human samples (tbl 4). Methods Mol Biol (2016) ncbi
mouse monoclonal (104D2)
  • flow cytometry; human
BioLegend C-kit antibody (Biolegend, 104D2) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
Invitrogen
mouse monoclonal (104D2)
  • flow cytometry; human; loading ...; fig e1a
Invitrogen C-kit antibody (eBioscience, 104D2) was used in flow cytometry on human samples (fig e1a). J Allergy Clin Immunol (2018) ncbi
mouse monoclonal (104D2)
  • flow cytometry; human; fig 1
In order to report that T lymphocytes activated with a sub-mitogenic or mitogenic stimulus, or immobilized via anti-CD3 + anti-CD28 mouse antibodies tightly bind allogenic mesenchymal stromal cells and transmigrate under them, Invitrogen C-kit antibody (Caltag, 104D2) was used in flow cytometry on human samples (fig 1). J Cell Physiol (2008) ncbi
mouse monoclonal (104D2)
  • flow cytometry; human; fig 3
In order to assess the use of CD33-related siglecs as markers of acute myeloid leukemia, Invitrogen C-kit antibody (Caltag-Medsystems, 104D2) was used in flow cytometry on human samples (fig 3). Leuk Res (2007) ncbi
Bio-Rad
mouse monoclonal (104D2)
  • flow cytometry; domestic sheep; 1:10; fig 3
In order to define a set of monoclonal antibodies for the immunophenotypic characterization of ovine mesenchymal stem cells, Bio-Rad C-kit antibody (AbD Serotec, MCA1841PET) was used in flow cytometry on domestic sheep samples at 1:10 (fig 3). Cytometry A (2016) ncbi
EMD Millipore
mouse monoclonal (YB5.B8)
  • flow cytometry; bovine; fig 4
EMD Millipore C-kit antibody (Chemicon, MAB1162F) was used in flow cytometry on bovine samples (fig 4). J Tissue Eng Regen Med (2017) ncbi
Articles Reviewed
  1. Ardain A, Domingo Gonzalez R, Das S, Kazer S, Howard N, Singh A, et al. Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis. Nature. 2019;: pubmed publisher
  2. Collins P, Cella M, Porter S, Li S, Gurewitz G, Hong H, et al. Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells. Cell. 2019;176:348-360.e12 pubmed publisher
  3. Bahri R, Custovic A, Korosec P, Tsoumani M, Barron M, Wu J, et al. Mast cell activation test in the diagnosis of allergic disease and anaphylaxis. J Allergy Clin Immunol. 2018;142:485-496.e16 pubmed publisher
  4. Jeffery H, McDowell P, Lutz P, Wawman R, Roberts S, Bagnall C, et al. Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score. PLoS ONE. 2017;12:e0188649 pubmed publisher
  5. Herndler Brandstetter D, Shan L, Yao Y, Stecher C, Plajer V, Lietzenmayer M, et al. Humanized mouse model supports development, function, and tissue residency of human natural killer cells. Proc Natl Acad Sci U S A. 2017;114:E9626-E9634 pubmed publisher
  6. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, et al. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. J Immunol. 2017;199:2777-2793 pubmed publisher
  7. Huang N, Pishesha N, Mukherjee J, Zhang S, Deshycka R, Sudaryo V, et al. Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin. Nat Commun. 2017;8:423 pubmed publisher
  8. Allan D, Cerdeira A, Ranjan A, Kirkham C, Aguilar O, Tanaka M, et al. Transcriptome analysis reveals similarities between human blood CD3- CD56bright cells and mouse CD127+ innate lymphoid cells. Sci Rep. 2017;7:3501 pubmed publisher
  9. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed publisher
  10. Lim A, Li Y, Lopez Lastra S, Stadhouders R, Paul F, Casrouge A, et al. Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation. Cell. 2017;168:1086-1100.e10 pubmed publisher
  11. Britschgi A, Duss S, Kim S, Couto J, Brinkhaus H, Koren S, et al. The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα. Nature. 2017;541:541-545 pubmed publisher
  12. Williams J, Dean A, Lankford S, Criswell T, Badlani G, Andersson K. Determinates of muscle precursor cell therapy efficacy in a nonhuman primate model of intrinsic urinary sphincter deficiency. Stem Cell Res Ther. 2017;8:1 pubmed publisher
  13. Khan M, Chandrashekran A, Smith R, Dudhia J. Immunophenotypic characterization of ovine mesenchymal stem cells. Cytometry A. 2016;89:443-50 pubmed publisher
  14. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  15. Ogaki S, Morooka M, Otera K, Kume S. A cost-effective system for differentiation of intestinal epithelium from human induced pluripotent stem cells. Sci Rep. 2015;5:17297 pubmed publisher
  16. Jackson J, Taylor J, Witek M, Hunsucker S, Waugh J, Fedoriw Y, et al. Microfluidics for the detection of minimal residual disease in acute myeloid leukemia patients using circulating leukemic cells selected from blood. Analyst. 2016;141:640-51 pubmed publisher
  17. Okoye Okafor U, Bartholdy B, Cartier J, Gao E, Pietrak B, Rendina A, et al. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015;11:878-86 pubmed publisher
  18. Bai H, Liu Y, Xie Y, Hoyle D, Brodsky R, Cheng L, et al. Definitive Hematopoietic Multipotent Progenitor Cells Are Transiently Generated From Hemogenic Endothelial Cells in Human Pluripotent Stem Cells. J Cell Physiol. 2016;231:1065-76 pubmed publisher
  19. Denkovskij J, Rudys R, Bernotiene E, Minderis M, Bagdonas S, Kirdaite G. Cell surface markers and exogenously induced PpIX in synovial mesenchymal stem cells. Cytometry A. 2015;87:1001-11 pubmed publisher
  20. Fernandez L, Valentin J, Zalacain M, Leung W, Patino Garcia A, Perez Martinez A. Activated and expanded natural killer cells target osteosarcoma tumor initiating cells in an NKG2D-NKG2DL dependent manner. Cancer Lett. 2015;368:54-63 pubmed publisher
  21. Hines W, Yaswen P, Bissell M. Modelling breast cancer requires identification and correction of a critical cell lineage-dependent transduction bias. Nat Commun. 2015;6:6927 pubmed publisher
  22. Axelsson Robertson R, Ju J, Kim H, Zumla A, Maeurer M. Mycobacterium tuberculosis-specific and MHC class I-restricted CD8+ T-cells exhibit a stem cell precursor-like phenotype in patients with active pulmonary tuberculosis. Int J Infect Dis. 2015;32:13-22 pubmed publisher
  23. Cruse G, Beaven M, Music S, Bradding P, Gilfillan A, Metcalfe D. The CD20 homologue MS4A4 directs trafficking of KIT toward clathrin-independent endocytosis pathways and thus regulates receptor signaling and recycling. Mol Biol Cell. 2015;26:1711-27 pubmed publisher
  24. Oliveira V, Mançanares C, Oliveira L, Gonçalves N, Miglino M, Perecin F, et al. Characterization of putative haematopoietic cells from bovine yolk sac. J Tissue Eng Regen Med. 2017;11:1132-1140 pubmed publisher
  25. Leung A, Murphy G. Multisystemic Disease Modeling of Liver-Derived Protein Folding Disorders Using Induced Pluripotent Stem Cells (iPSCs). Methods Mol Biol. 2016;1353:261-70 pubmed publisher
  26. Mandl M, Schmitz S, Weber C, Hristov M. Characterization of the CD14++CD16+ monocyte population in human bone marrow. PLoS ONE. 2014;9:e112140 pubmed publisher
  27. Suva D, Passweg J, Arnaudeau S, Hoffmeyer P, Kindler V. In vitro activated human T lymphocytes very efficiently attach to allogenic multipotent mesenchymal stromal cells and transmigrate under them. J Cell Physiol. 2008;214:588-94 pubmed
  28. Biedermann B, Gil D, Bowen D, Crocker P. Analysis of the CD33-related siglec family reveals that Siglec-9 is an endocytic receptor expressed on subsets of acute myeloid leukemia cells and absent from normal hematopoietic progenitors. Leuk Res. 2007;31:211-20 pubmed